BioLink
PrivateLast Round
Strategic
Nov 14, 2024
Company Overview
BioLink is a life sciences company that provides process solutions, equipment, and consumables for the manufacturing of biopharmaceuticals, including vaccines, antibodies, and cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLink Comparables
Compare BioLink with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cobetter Filtration | 81% | |
| Pinshan Biotechnology (Shanghai) Co., Ltd. | 80% | |
| Suzhou Womei Biology Co., Ltd. | 79% |
BioLink Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 14, 2024 | ||||
| Series A Extension | Feb 21, 2024 | ||||
| Series A | Dec 1, 2022 |
BioLink Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series A Extension, Series A, Strategic |
| Alwin Capital | Strategic |
| Boyu Capital | Series A |
| Zoo Capital | Strategic |
| Shenzhen Capital Group | Strategic |
| Apricot Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Grew 20% QoQ, from 45 to 54 employees.
- Dec 26, 2025
Grew 16% QoQ, from 45 to 52 employees.
BioLink Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioLink's valuation, stock price, and market status.
Is BioLink a public or private company?
BioLink is a private company.
What is the current stock price of BioLink?
BioLink is a private company with no public stock price. No recent secondary market data is available.
How much is BioLink worth (valuation)?
Valuation information for BioLink is not publicly available.
Can I buy BioLink stock?
BioLink shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioLink's last funding round?
BioLink's most recent funding round was Strategic on November 14, 2024.
Who are the main investors in BioLink?
Key investors in BioLink include Cathay Capital.
Will BioLink IPO soon?
No public IPO plans have been announced for BioLink.
How can I track BioLink secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioLink's secondary market activity and sign up for updates.